This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
22 May 2019

Zenith Technologies sees 400% China growth in latest Asia success

L-R Liang Zhou, General Manager China on the left and Trevor Marshall, Global Engineering Director.

Company plans to double its operations in the country over the next 3 years and expand its work with local companies as well as continuing to support global multinationals.

Zenith Technologies, a world leader in delivering manufacturing software solutions to the life sciences industry, has reported 400% growth in its Chinese operations in the last 3 years.

The company now has a presence working on sites across five Chinese cities – Shanghai, Suzhou, Xi’an, Hangzhou & Guangzhou - and employs a growing team to work across its client base supporting pharma and biotech companies with the implementation of technologies to improve manufacturing efficiencies such as automation, IT, manufacturing execution systems (MES) and digital and data analysis.

With the Chinese life sciences market currently set as the world’s second largest national market, and with an expected value of $220 billion by 2022, Zenith plans to double its operations in the country over the next 3 years and expand its work with local companies as well as continuing to support global multinationals.

Liang Zhou, General Manager of Greater China said: “The Chinese market has been leading the way in revolutionary cell therapy innovations, which are changing the face of medicine delivery. There is growing interest in the adoption of automating processes in this area as companies build a new generation of facilities in line with stringent international standards with a view to supplying across the world.

“We are well placed to support clients here who would like to adopt these solutions and have already played an integral role in the development of technologies to oversee these key cell therapy innovations.”

Zenith’s success in China represents the company’s latest endeavour in the Asian market having first set up a presence on the continent in 2002 with the opening of its regional headquarters in Singapore.

In 2008 the company set up an office in India, which now hosts more than 100 employees and serves as a global support hub to deliver software projects anywhere in the world, featuring a remote engineering centre and 24/7 IT support desk service.

Across the continent, Zenith now has a total workforce of more than 200 professionals and is actively looking to new Asian markets to expand its footprint to support the burgeoning number of life science hubs.

Bryan McSwiney, Asia Director said: “After more than 15 years in the Asian market, a quarter of our global operations are now based here and the latest growth figures from China demonstrate that we go from strength to strength.

“We now have an established presence in five Chinese cities – a significant footprint within a relatively short space of time – as well as a thriving support hub in India and a widely recognised HQ in Singapore.

“With a solid foundation now firmly established in the Asian market, we look forward to building on our successes and working closely with local and multinational companies on the continent who can benefit from the diverse range of technologies we can introduce into manufacturing facilities.”

Related News